Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLC - James Chih-Hsin Yang; Shun Lu; Hidetoshi Hayashi; Enriqueta Felip; Alexander I. Spira; Nicolas Girard; Yu Jung Kim; Se-Hoon Lee; Yurii Ostapenko; Pongwut Danchaivijitr; Baogang Liu; Adlinda Alip; et al. (New England Journal of Medicine, 2025)